Idarubicin Hydrochloride
Overview
Idarubicin Hydrochloride is an anthracycline antineoplastic used in the treatment of certain types of cancer, including acute myeloid leukemia. It works by intercalating DNA, thereby inhibiting the synthesis of nucleic acids and causing cell death.
API suppliers (3)
Suppliers of Idarubicin Hydrochloride evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 2 of 3 suppliers.
- TAPI NL BVNetherlands1 active DMF
- SYNBIAS PHARMA AGFrance
- PHARMACIA AND UPJOHN SUB PFIZER INC
Therapeutic areas
Do you supply Idarubicin Hydrochloride? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.